CPA
PAHC icon

Capital Performance Advisors’s Phibro Animal Health PAHC Stock Holding History

Capital Performance Advisors’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-373
Closed -$8.4K – 1921
2024
Q3 		$8.4K Buy
+373
New +$7.2K ﹤0.01% 908

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Capital Performance Advisors's PAHC Position: Q4 2024 in Review

Capital Performance Advisors sold out of Phibro Animal Health (PAHC) in Q4 2024, closing a stake of 373 shares — an estimated $8.4K sold.

Capital Performance Advisors first reported a position in PAHC in Q3 2024 and held it in 1 quarter. The position peaked at $8.4K in Q3 2024. 172 funds tracked by Wall St. Rank hold PAHC as of Q4 2024.

  • Capital Performance Advisors reported no remaining Phibro Animal Health position as of Q4 2024 after selling out during the quarter.
  • Capital Performance Advisors sold 373 Phibro Animal Health shares in Q4 2024, an estimated $8.4K.
  • Capital Performance Advisors first reported a position in Phibro Animal Health in Q3 2024 and held it in 1 quarter.
  • Capital Performance Advisors's Phibro Animal Health position peaked at $8.4K in Q3 2024.
  • 172 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2024.

Based on Capital Performance Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.